3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pancreatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Esophageal Squamous Cell Carcinoma
5
Triple Negative Breast Neoplasms
3
Neoplasms
3
Head and Neck Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Uterine Cervical Neoplasms
1
Thymoma
1
Thymic epithelial tumor
1
Squamous NSCLC
1
Small Cell Lung Carcinoma
1
Salivary Gland Malignant Neoplasms
1
Pathologic Complete Response
1
Pancreatic cancer, adult
1
Pancreatic Cancer Resectable
1
Melanoma
1
Mediastinal Neoplasms
1
Locally Advanced Non-Small Cell Lung Cancer
1
Gastric Adenocarcinoma
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Carcinoma
1
Carcinoma
1
Brain Neoplasms
1
Anophthalmia with pulmonary hypoplasia
1
Advanced Triple Negative Breast Cancer
1
Interventions
lenvatinib
1
camrelizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Advanced Triple Negative Breast Cancer
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT06849492
2025-02-27
SHIFT-001
Fudan University
Phase 2
Not yet recruiting
120 enrolled